Tag Archive for: pharmather
https://psychedelicspotlight.com/wp-content/uploads/2021/10/Psychedelic_Spotlight_Business_Spotlight_October_8.jpg 962 1920 Emily Jarvie https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Emily Jarvie2021-10-08 16:51:252022-06-07 23:24:14Psychedelic Business Spotlight: October 8, 2021
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat Parkinson's Disease.
https://psychedelicspotlight.com/wp-content/uploads/2021/08/ketamine_treatment_als_psychedelic_spotlight.jpg 850 1310 Emily Jarvie https://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.png Emily Jarvie2021-08-04 16:16:562021-08-04 16:17:00FDA Green Lights Ketamine for Treatment of ALS
"This designation not only expedites our regulatory, clinical, and product development plans but also validates our belief in the potential of ketamine," says PharmaTher CEO Fabio Chianelli.